Cullen KJ - Search Results

1

Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.

Li Z, Liao J, Yang Z, Choi EY, Lapidus RG, Liu X, Cullen KJ, Dan H. Li Z, et al. Among authors: cullen kj. Br J Cancer. 2019 Feb;120(3):306-316. doi: 10.1038/s41416-018-0351-z. Epub 2018 Dec 26. Br J Cancer. 2019. PMID: 30585254 Free PMC article.

2

IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancer.

Li Z, Yang Z, Lapidus RG, Liu X, Cullen KJ, Dan HC. Li Z, et al. Among authors: cullen kj. Am J Cancer Res. 2015 Sep 15;5(10):3098-110. eCollection 2015. Am J Cancer Res. 2015. PMID: 26693062 Free PMC article.

3

A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.

Li Z, Yang Z, Passaniti A, Lapidus RG, Liu X, Cullen KJ, Dan HC. Li Z, et al. Among authors: cullen kj. Oncotarget. 2016 May 31;7(22):31892-906. doi: 10.18632/oncotarget.7441. Oncotarget. 2016. PMID: 26895469 Free PMC article.

4

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.

Yang Z, Liao J, Carter-Cooper BA, Lapidus RG, Cullen KJ, Dan H. Yang Z, et al. Among authors: cullen kj. BMC Cancer. 2019 May 22;19(1):485. doi: 10.1186/s12885-019-5664-7. BMC Cancer. 2019. PMID: 31118072 Free PMC article.

5

Inhibition of cisplatin-resistant head and neck squamous cell carcinoma by combination of Afatinib with PD0325901, a MEK inhibitor.

Lin X, Liao J, Yang Z, Fan X, Cullen KJ, Chen L, Dan H. Lin X, et al. Among authors: cullen kj. Am J Cancer Res. 2019 Jun 1;9(6):1282-1292. eCollection 2019. Am J Cancer Res. 2019. PMID: 31285959 Free PMC article.

6

Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition.

Liao J, Yang Z, Carter-Cooper B, Chang ET, Choi EY, Kallakury B, Liu X, Lapidus RG, Cullen KJ, Dan H. Liao J, et al. Among authors: cullen kj. Clin Exp Metastasis. 2020 Apr;37(2):283-292. doi: 10.1007/s10585-020-10021-7. Epub 2020 Feb 4. Clin Exp Metastasis. 2020. PMID: 32020377 Free PMC article.

7

Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma.

Yang Z, Liao J, Cullen KJ, Dan H. Yang Z, et al. Among authors: cullen kj. Cell Death Discov. 2020 May 15;6:36. doi: 10.1038/s41420-020-0270-7. eCollection 2020. Cell Death Discov. 2020. PMID: 32435511 Free PMC article.

8

[No title available]

[No authors listed] [No authors listed] PMID: 33563938

9

Targeting Wee1 kinase to suppress proliferation and survival of cisplatin-resistant head and neck squamous cell carcinoma.

Yang Z, Liao J, Lapidus RG, Fan X, Mehra R, Cullen KJ, Dan H. Yang Z, et al. Among authors: cullen kj. Cancer Chemother Pharmacol. 2022 Apr;89(4):469-478. doi: 10.1007/s00280-022-04410-w. Epub 2022 Feb 25. Cancer Chemother Pharmacol. 2022. PMID: 35212780

10

Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma.

Yang Z, Liao J, Schumaker L, Carter-Cooper B, Lapidus RG, Fan X, Gaykalova DA, Mehra R, Cullen KJ, Dan H. Yang Z, et al. Among authors: cullen kj. Oral Oncol. 2022 Aug;131:105939. doi: 10.1016/j.oraloncology.2022.105939. Epub 2022 Jun 3. Oral Oncol. 2022. PMID: 35667295

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters